Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Leishmania major | DNA polymerase eta, putative | 0.0034 | 0.4775 | 0.4775 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0027 | 0.2319 | 0.2319 |
Brugia malayi | hypothetical protein | 0.0027 | 0.2319 | 0.2319 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0027 | 0.2319 | 0.5 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0027 | 0.2319 | 0.5 |
Trypanosoma brucei | DNA polymerase eta, putative | 0.0049 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0049 | 1 | 1 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.0034 | 0.4775 | 0.4775 |
Schistosoma mansoni | DNA polymerase eta | 0.0049 | 1 | 1 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.0027 | 0.2319 | 0.5 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0027 | 0.2319 | 0.2319 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0021 | 0 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0027 | 0.2319 | 0.2319 |
Echinococcus granulosus | dna polymerase eta | 0.0049 | 1 | 1 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0021 | 0 | 0.5 |
Entamoeba histolytica | deoxycytidyl transferase, putative | 0.0021 | 0 | 0.5 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.0027 | 0.2319 | 0.2319 |
Leishmania major | DNA polymerase eta, putative | 0.0049 | 1 | 1 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0021 | 0 | 0.5 |
Trichomonas vaginalis | DNA polymerase eta, putative | 0.0021 | 0 | 0.5 |
Echinococcus multilocularis | dna polymerase eta | 0.0049 | 1 | 1 |
Toxoplasma gondii | ImpB/MucB/SamB family protein | 0.0034 | 0.4775 | 1 |
Trichomonas vaginalis | DNA polymerase IV / kappa, putative | 0.0021 | 0 | 0.5 |
Giardia lamblia | DINP protein human, muc B family | 0.0021 | 0 | 0.5 |
Mycobacterium tuberculosis | Possible DNA-damage-inducible protein P DinP (DNA polymerase V) (pol IV 2) (DNA nucleotidyltransferase (DNA-directed)) | 0.0021 | 0 | 0.5 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.0049 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 0.2319 | 0.2319 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition (binding) | = 34.81 % | Inhibition of ovine COX1 assessed as reduction in PGF2alpha formation at 10 uM incubated for 18 hrs by enzyme immunoassay | ChEMBL. | 25219899 |
Inhibition (binding) | = 69.14 % | Inhibition of ovine COX2 assessed as reduction in PGF2alpha formation at 10 uM incubated for 18 hrs by enzyme immunoassay | ChEMBL. | 25219899 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.